Anebulo Pharmaceuticals Inc Financial Flexibility Index
Anebulo Pharmaceuticals Inc financial flexibility index. Anebulo Pharmaceuticals Inc (ANEB) has a Financial Flexibility Index of -0.88x as of December 2025. Free cash flow of $-1.31 Million (operating CF $-1.31 Million minus capex $0.00) represents -1% of total liabilities ($1.49 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Anebulo Pharmaceuticals Inc (2020–2025)
Financial flexibility index of Anebulo Pharmaceuticals Inc from 2020 to 2025. Historical Financial Flexibility Index trend for Anebulo Pharmaceuticals Inc across 6 annual periods. Explore how well can Anebulo Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Anebulo Pharmaceuticals Inc Financial Flexibility Index by Year (2020–2025)
Anebulo Pharmaceuticals Inc financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Anebulo Pharmaceuticals Inc. For the full cash flow conversion analysis, see Anebulo Pharmaceuticals Inc (ANEB) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.02x | $-6.35 Million | $-6.35 Million | $487.69K | ▲ +58.1% |
| 2024 | -31.05x | $-8.09 Million | $-8.09 Million | $260.58K | ▼ -242.7% |
| 2023 | -9.06x | $-9.68 Million | $-9.68 Million | $1.07 Million | ▲ +14.6% |
| 2022 | -10.61x | $-5.44 Million | $-5.44 Million | $512.53K | ▲ +47.4% |
| 2021 | -20.16x | $-4.87 Million | $-4.87 Million | $241.63K | ▼ -2893.3% |
| 2020 | -0.67x | $-150.77K | $-150.77K | $223.87K | — |